Cargando…

Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study

INTRODUCTION: Risks of poor information transfer across health settings are well documented, particularly for medication. There is also increasing awareness of the importance of greater patient activation. Patients may use various types of patient-held information about medication (PHIMed) to facili...

Descripción completa

Detalles Bibliográficos
Autores principales: Garfield, Sara, Furniss, Dominic, Husson, Fran, Turley, Margaret, Dean Franklin, Bryony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042590/
https://www.ncbi.nlm.nih.gov/pubmed/29950473
http://dx.doi.org/10.1136/bmjopen-2018-021764
_version_ 1783339186197102592
author Garfield, Sara
Furniss, Dominic
Husson, Fran
Turley, Margaret
Dean Franklin, Bryony
author_facet Garfield, Sara
Furniss, Dominic
Husson, Fran
Turley, Margaret
Dean Franklin, Bryony
author_sort Garfield, Sara
collection PubMed
description INTRODUCTION: Risks of poor information transfer across health settings are well documented, particularly for medication. There is also increasing awareness of the importance of greater patient activation. Patients may use various types of patient-held information about medication (PHIMed) to facilitate medication transfer, which may be paper or electronic. However, it is not known how PHIMed should best be used, whether it improves patient outcomes, nor is its key ‘active ingredients’ known. Discussion with patients and carers has highlighted this as a priority for research. We aim to identify how PHIMed is used in practice, barriers and facilitators to its use and key features of PHIMed that support medicines optimisation in practice. METHODS AND ANALYSIS: This study will take place in Greater London, England. We will include patients with long-term conditions, carers and healthcare professionals. The study has four work packages (WPs). WP1 involves qualitative interviews with healthcare professionals (n=16) and focus groups with patients and carers (n=20), including users and non-users of PHIMed, to study perceptions around its role, key features, barriers and facilitators, and any unintended consequences. WP2 will involve documentary analysis of how PHIMed is used, what is documented and read, and by whom, in a stratified sample of 60 PHIMed users. In WP3, we will carry out a descriptive analysis of PHIMed tools used/available, both electronic and paper, and categorise their design and key features based on those identified in WP1/2. Finally, in WP4, findings from WPs 1–3 will be integrated and analysed using distributed cognition as a theoretical framework to explore how information is recorded, transformed and propagated among different people and artefacts. ETHICS AND DISSEMINATION: The study has National Health Service ethics approval. It will provide initial recommendations around the present use of PHIMed to optimise patient care for patients, carers and healthcare professionals.
format Online
Article
Text
id pubmed-6042590
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-60425902018-07-16 Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study Garfield, Sara Furniss, Dominic Husson, Fran Turley, Margaret Dean Franklin, Bryony BMJ Open Patient-Centred Medicine INTRODUCTION: Risks of poor information transfer across health settings are well documented, particularly for medication. There is also increasing awareness of the importance of greater patient activation. Patients may use various types of patient-held information about medication (PHIMed) to facilitate medication transfer, which may be paper or electronic. However, it is not known how PHIMed should best be used, whether it improves patient outcomes, nor is its key ‘active ingredients’ known. Discussion with patients and carers has highlighted this as a priority for research. We aim to identify how PHIMed is used in practice, barriers and facilitators to its use and key features of PHIMed that support medicines optimisation in practice. METHODS AND ANALYSIS: This study will take place in Greater London, England. We will include patients with long-term conditions, carers and healthcare professionals. The study has four work packages (WPs). WP1 involves qualitative interviews with healthcare professionals (n=16) and focus groups with patients and carers (n=20), including users and non-users of PHIMed, to study perceptions around its role, key features, barriers and facilitators, and any unintended consequences. WP2 will involve documentary analysis of how PHIMed is used, what is documented and read, and by whom, in a stratified sample of 60 PHIMed users. In WP3, we will carry out a descriptive analysis of PHIMed tools used/available, both electronic and paper, and categorise their design and key features based on those identified in WP1/2. Finally, in WP4, findings from WPs 1–3 will be integrated and analysed using distributed cognition as a theoretical framework to explore how information is recorded, transformed and propagated among different people and artefacts. ETHICS AND DISSEMINATION: The study has National Health Service ethics approval. It will provide initial recommendations around the present use of PHIMed to optimise patient care for patients, carers and healthcare professionals. BMJ Publishing Group 2018-06-27 /pmc/articles/PMC6042590/ /pubmed/29950473 http://dx.doi.org/10.1136/bmjopen-2018-021764 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Patient-Centred Medicine
Garfield, Sara
Furniss, Dominic
Husson, Fran
Turley, Margaret
Dean Franklin, Bryony
Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study
title Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study
title_full Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study
title_fullStr Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study
title_full_unstemmed Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study
title_short Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study
title_sort use of patient-held information about medication (phimed) to support medicines optimisation: protocol for a mixed-methods descriptive study
topic Patient-Centred Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042590/
https://www.ncbi.nlm.nih.gov/pubmed/29950473
http://dx.doi.org/10.1136/bmjopen-2018-021764
work_keys_str_mv AT garfieldsara useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy
AT furnissdominic useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy
AT hussonfran useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy
AT turleymargaret useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy
AT deanfranklinbryony useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy